This is the authors' abstract. We don't add key points for this paper.
ACEI showed anti-fibrotic properties in scar formation by mediating downstream peptides to suppress TGF-β1/Smad and TGF-β1/TAK1 pathways. These findings suggest that dual inhibition of Smad and TAK1 signalling by ACEI is a useful strategy for the development of new anti-fibrotic agents.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: